De Micheli AJ, Laurilliard EJ, Heinke CL, Ravichandran H, Fraczek P, Soueid-Baumgarten S, De Vlaminck I, Elemento O, Cosgrove BD.
2020.
Single-Cell Analysis of the Muscle Stem Cell Hierarchy Identifies Heterotypic Communication Signals Involved in Skeletal Muscle Regeneration.. Cell Rep. 30(10):3583-3595.e5.
Venturutti L, Teater M, Zhai A, Chadburn A, Babiker L, Kim D, Béguelin W, Lee TC, Kim Y, Chin CR et al..
2020.
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.. Cell. 182(2):297-316.e27.
Vanmeerbeek I, Sprooten J, De Ruysscher D, Tejpar S, Vandenberghe P, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L et al..
2020.
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.. Oncoimmunology. 9(1):1703449.
Frega G, Wu Q, Le Naour J, Vacchelli E, Galluzzi L, Kroemer G, Kepp O.
2020.
Trial Watch: experimental TLR7/TLR8 agonists for oncological indications.. Oncoimmunology. 9(1):1796002.
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E.
2020.
Trial watch: IDO inhibitors in cancer therapy.. Oncoimmunology. 9(1):1777625.
Le Naour J, Zitvogel L, Galluzzi L, Vacchelli E, Kroemer G.
2020.
Trial watch: STING agonists in cancer therapy.. Oncoimmunology. 9(1):1777624.
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E.
2020.
Trial watch: TLR3 agonists in cancer therapy.. Oncoimmunology. 9(1):1771143.
Pine AR, Cirigliano SM, Nicholson JG, Hu Y, Linkous A, Miyaguchi K, Edwards L, Singhania R, Schwartz TH, Ramakrishna R et al..
2020.
Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas.. Cancer Discov. 10(7):964-979.
Chu C-S, Hellmuth JC, Singh R, Ying H-Y, Skrabanek L, Teater MR, Doane AS, Elemento O, Melnick AM, Roeder RG.
2020.
Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage.. Mol Cell. 80(5):845-861.e10.
Dooley BJ, Verma A, Ding R, Yang H, Muthukumar T, Lubetzky M, Shankaranarayanan D, Elemento O, Suthanthiran M.
2020.
Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts.. Transplant Direct. 6(8):e588.